TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
- Industry at a Glance
- Scope and Methodology
- Size and Growth of the Market
- Key Issues and Trends Affecting the Market
- Leading Market Participants
CHAPTER TWO: INDUSTRY OVERVIEW
- Clinical Laboratory Description
- Testing and Services
- Routine Testing
- Blood Cell Coun
- Cholesterol Level Testing
- HIV Testing
- Anti-HIV-1 Oral Specimen Collection Device
- Anti-HIV-1 Testing Service
- Nucleic Acid Testing
- Human Immunodeficiency Virus Type 1 (Anti-HIV-1 Assay)
- Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay)
- Pap Testing
- Pregnancy Testing
- Substance Abuse Testing
- Urinalysis
- Specialty Testing
- Endocrinology
- Esoteric Testing
- Genetics
- Immunology and Molecular Microbiology
- Oncology
- Serology
- Toxicology
- Industry Structure
- Hospital-based Laboratories
- Physician-office Laboratories
- Independent Clinical Laboratories
- Incidence of Diseases
- Demographics
- Population Over Age 65
- Life Expectancy
- Regulatory Overview
- Certificate of Waiver
- Certificate of Provider-Performed Microscopy Procedures (PPMP)
- Certificate of Compliance and Certificate of Accreditation States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
- Insurance and Reimbursement
- Laboratory Service Payer Types
- Commercial Insurance Providers
- New Developments
- International Markets and Trends
CHAPTER THREE: LEADING MARKET PARTICIPANTS
- Summary
- Quest Diagnostics, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Business Locations
- Laboratory Corporation of America
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- Genzyme Corporation
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- DaVita
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- Clarient, Inc.
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- Spectra Laboratories
- Company Overview
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
- BIO-REFERENCE LABORATORIES
- Company Overview
- Performance Review
- Key Acquisitions, Alliances, and Partnerships
- Products and Services
- Growth Strategy
- Locations
CHAPTER FOUR: MARKET TRENDS AND SUMMARY
- Market Overview
- Market Analysis by Laboratory Type
- Market Analysis by Test Type
- Competitive Analysis
CHAPTER FIVE: LIST OF MAJOR COMPANIES AND ORGANIZATIONS
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1: U.S. Clinical Laboratory Market Analysis: 2005-2012
CHAPTER TWO: INDUSTRY OVERVIEW
- Table 2-1: Laboratory Reference Parameters for CBC
- Table 2-2: High Cholesterol Risk Categories
- Table 2-3: HIV Testing Products/Services Approved by the FDA
- Table 2-4: HCG Levels in Pregnant Women by Days Past Ovulation
- Table 2-5: Substance Detection Periods by Test Method
- Figure 2-1: Growth in Clinical Laboratories, 1997-2007
- Table 2-6: U.S. Registered Hospitals by Type, 2006
- Table 2-7: Leading For-Profit U.S. Hospital Chains, 2006
- Table 2-8: Physicians in the US by Specialty, 1970-2000
- Table 2-9: Leading U.S. Independent Laboratory Groups, 2007
- Table 2-10: U.S. Prevalence of Selected Medical Conditions
- Figure 2-2: U.S. Prevalence of Selected Medical Conditions
- Table 2-11: The U.S. Population, 1980-2020
- Figure 2-3: The US Population, 1980-2020
- Table 2-12: Percent U.S. Population Over Age 65 by Year
- Figure 2-4: Estimated Population by Age Group, 2000 and 2050
- Table 2-13: Average U.S. Life Expectancy in Years 1980, 2004 and 2006
- Figure 2-5: Average U.S. Life Expectancy in Years 1980 and 2006
- Table 2-14: Selected CLIA Waived Laboratory Tests
- Table 2-15: Provider-Performed Microscopy Procedures
- Figure 2-6: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), December 2007
- Table 2-16: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), December 2007
- Figure 2-7: Clinical Laboratory Certificates Issued by Selected State (non-exempt laboratories only), December 2007
- Figure 2-8: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), December 2007
- Table 2-17: CLIA Exempt States, Number of Laboratories, 2007
- Table 2-18: Health Insurance Trends in the United States, Estimated 2007 (millions)
- Table 2-19: Clinical Laboratory Clients and Payers by Type
- Figure 2-9: Clinical Laboratory Clients and Payers by Type
- Table 2-20: Leading Commercial Insurance Providers, 2007
- Table 2-21: Quest and LabCorp Service Contracts for Leading Insurance Providers
CHAPTER THREE: LEADING MARKET PARTICIPANTS
- Table 3-1: Corporate Details of Quest Diagnostics
- Figure 3-1: Quest Diagnostics¡¯ Clinical Testing Sales to Third Parties, 2005-2007 ($millions)
- Table 3-2: Corporate Details of Laboratory Corporation of America
- Figure 3: : Laboratory Corporation of America¡¯s Sales to Third Parties, 2005-2007 ($millions)
- Table 3-3: Corporate Details of Genzyme Corporation
- Figure 3-3: Genzyme Corporation Genetics/Diagnostics Sales to Third Parties, 2005-2007 ($millions)
- Table 3-4: Corporate Details of DaVita
- Figure 3-4: DaVita¡¯s Laboratory Service Revenues, 2006 and 2007
- Table 3-5: Corporate Details of Clarient
- Figure 3-5: Clarient¡¯s Sales to Third Parties, 2005-2007
- Table 3-6: Corporate Details of Fresenius Medical Care AG
- Table 3-7: Corporate Details of Bio-Reference Laboratories
- Figure 3-6: Bio-Reference¡¯s Sales to Third Parties, 2005-2007
CHAPTER FOUR: MARKET TRENDS AND SUMMARY
- Table 4-1: U.S. Clinical Laboratory Market Analysis, 2005-2007
- Table 4-2: Forecasted U.S. Clinical Laboratory Market Analysis: 2008-2012
- Figure 4-1: U.S. Clinical Laboratory Market Analysis: 2005-2012
- Table 4-3: U.S. Clinical Laboratory Market Analysis by Type, 2005-2007
- Table 4-4: Forecasted U.S. Clinical Laboratory Market Analysis by Type, 2008-2012
- Figure 4-2: U.S. Clinical Laboratory Market Analysis by Type, 2005-2012
- Figure 4-3: U.S. Clinical Laboratory Market Share by Type, 2007
- Figure 4-4: U.S. Clinical Laboratory Market Share by Type, 2012
- Table 4-5: U.S. Clinical Laboratory Market Analysis by General Test Type, 2007
- Figure 4-5: U.S. Clinical Laboratory Market Analysis by General Test Type, 2007
- Table 4-6: Estimated Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2007
- Figure 4-6: Estimated Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2007
|